AT
REGN icon

Arden Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Arden Trust’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10
Closed -$5K – 657
2020
Q1 		$5K Buy
+10
New +$4.13K ﹤0.01% 640
2019
Q1 		– Sell
-1,180
Closed -$441K – 380
2018
Q4 		$441K Sell
1,180
-131
-10% -$47.9K 0.08% 218
2018
Q3 		$530K Sell
1,311
-113
-8% -$43K 0.08% 219
2018
Q2 		$491K Sell
1,424
-74
-5% -$23.1K 0.08% 220
2018
Q1 		$516K Sell
1,498
-38
-2% -$13.2K 0.08% 216
2017
Q4 		$577K Buy
1,536
+89
+6% +$36K 0.09% 201
2017
Q3 		$647K Sell
1,447
-14
-1% -$6.66K 0.1% 197
2017
Q2 		$717K Sell
1,461
-226
-13% -$98.9K 0.11% 187
2017
Q1 		$653K Sell
1,687
-287
-15% -$106K 0.1% 185
2016
Q4 		$725K Buy
1,974
+324
+20% +$123K 0.11% 185
2016
Q3 		$663K Sell
1,650
-2,479
-60% -$994K 0.1% 184
2016
Q2 		$1.44K Sell
4,129
-71
-2% -$27.3K 0.11% 188
2016
Q1 		$1.51M Sell
4,200
-382
-8% -$157K 0.12% 179
2015
Q4 		$2.49M Sell
4,582
-2,670
-37% -$1.45M 0.21% 114
2015
Q3 		$3.37M Buy
7,252
+5,685
+363% +$3.05M 0.28% 93
2015
Q2 		$799 Sell
1,567
-103
-6% -$50.3K 0.12% 209
2015
Q1 		$754 Buy
1,670
+137
+9% +$58.1K 0.11% 226
2014
Q4 		$629K Sell
1,533
-113
-7% -$44.4K 0.09% 204
2014
Q3 		$594K Buy
+1,646
New +$552K 0.08% 215

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Arden Trust's REGN Position: Q2 2020 in Review

Arden Trust sold out of Regeneron Pharmaceuticals (REGN) in Q2 2020, closing a stake of 10 shares — an estimated $5K sold.

Arden Trust first reported a position in REGN in Q3 2014 and held it in 19 quarters. The position peaked at $3.37M in Q3 2015. 932 funds tracked by Wall St. Rank hold REGN as of Q2 2020.

  • Arden Trust reported no remaining Regeneron Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Arden Trust sold 10 Regeneron Pharmaceuticals shares in Q2 2020, an estimated $5K.
  • Arden Trust first reported a position in Regeneron Pharmaceuticals in Q3 2014 and held it in 19 quarters.
  • Arden Trust's Regeneron Pharmaceuticals position peaked at $3.37M in Q3 2015.
  • 932 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2020.

Based on Arden Trust's 13F filing for Q2 2020, filed 9 Jul 2020.